ArticleOncotarget2017

Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.

Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.